SMI Expanded

SMI Expanded handeln
1.804,28 PKT +1,60 PKT +0,09 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0019399861


Analysen zu SMI Expanded-Werten

Datum Rating Analyst
05.01.24 DocMorris Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
04.01.24 Swiss Re Sector Perform RBC Capital Markets
04.01.24 ABB (Asea Brown Boveri) Market-Perform Bernstein Research
03.01.24 Novartis Neutral JP Morgan Chase & Co.
03.01.24 Richemont Buy UBS AG
03.01.24 Novartis Buy Jefferies & Company Inc.
03.01.24 Roche Hold Jefferies & Company Inc.
02.01.24 DocMorris Buy Jefferies & Company Inc.
02.01.24 Richemont Outperform Bernstein Research
02.01.24 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
02.01.24 Roche Underweight JP Morgan Chase & Co.
28.12.23 Nestlé Market-Perform Bernstein Research
21.12.23 Novartis Underweight Barclays Capital
20.12.23 DocMorris Buy Deutsche Bank AG
20.12.23 UBS Outperform RBC Capital Markets
19.12.23 Richemont Overweight Barclays Capital
19.12.23 Nestlé Overweight Barclays Capital
19.12.23 Givaudan Underweight Barclays Capital
19.12.23 Givaudan Hold Deutsche Bank AG
19.12.23 Novartis Buy Deutsche Bank AG
19.12.23 Nestlé Buy Deutsche Bank AG
19.12.23 Zurich Insurance Buy UBS AG
19.12.23 Swiss Re Sell UBS AG
19.12.23 Givaudan Sell UBS AG
19.12.23 Richemont Buy UBS AG
18.12.23 Nestlé Buy UBS AG
18.12.23 ABB (Asea Brown Boveri) Neutral UBS AG
18.12.23 Roche Sell Deutsche Bank AG
15.12.23 Swiss Re Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14.12.23 ams-OSRAM Buy Jefferies & Company Inc.
13.12.23 Nestlé Overweight JP Morgan Chase & Co.
13.12.23 DocMorris Add Baader Bank
13.12.23 ams-OSRAM Neutral JP Morgan Chase & Co.
13.12.23 Givaudan Sell UBS AG
13.12.23 Richemont Overweight JP Morgan Chase & Co.
13.12.23 Richemont Buy Jefferies & Company Inc.
12.12.23 Richemont Sector Perform RBC Capital Markets
12.12.23 Nestlé Underperform RBC Capital Markets
12.12.23 Givaudan Underperform Jefferies & Company Inc.
11.12.23 Roche Underweight JP Morgan Chase & Co.